Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report